Clicky

Depression

12 Tips for Managing Anxiety, Depression During COVID-19

Share on PinterestThe COVID-19 pandemic has triggered worsening symptoms for many who are living with anxiety or depression, while simultaneously making it more difficult to get treatment. Justin Case/Getty Images Prescription fills for depression and anxiety peaked in 2020. Symptoms of depression and anxiety have worsened during the pandemic. There are ways to help with […]

12 Tips for Managing Anxiety, Depression During COVID-19 Read More »

Here’s how we’re targeting COVID-19 depression and anxiety

Although Australia is now largely COVID-free, the repercussions of the pandemic are ongoing. As the pandemic enters its second year, many people will be continuing to suffer with poor mental health, or facing new mental health challenges. The effects of recurrent lockdowns, fears about the effectiveness of the vaccines, restricted movement within and beyond Australia,

Here’s how we’re targeting COVID-19 depression and anxiety Read More »

What Is Clinical Depression (Major Depressive Disorder)?

Clinical depression, also called major depression or major depressive disorder (MDD), is often confused with having a sad or low mood. Although feeling sad is one symptom of clinical depression, there must be several other signs and symptoms—in addition to sadness—for someone to be formally diagnosed with clinical depression. Clinical depression is considered a potentially chronic

What Is Clinical Depression (Major Depressive Disorder)? Read More »

Multiple Sclerosis and Depression: Are Links Causal?

Relationships between multiple sclerosis (MS) and depression did not appear to be causal, a Mendelian randomization study suggested. Genetic liability to major depressive disorder had no effect on the odds of MS, reported Adil Harroud, MD, of the University of California San Francisco, and colleagues, at ACTRIMS Forum 2021, the annual meeting of the Americas

Multiple Sclerosis and Depression: Are Links Causal? Read More »

Ehave Couples KetaDASH with Digital Therapeutics Expertise to Combat Clinical Depression Other OTC:EHVVF

MIAMI, Feb. 01, 2021 (GLOBE NEWSWIRE) — Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, is announcing plans to roll out its ketamine home delivery platform known as KetaDASH. The backbone for KetaDASH will be Ehave’s expertise in the area of digital therapeutics, which

Ehave Couples KetaDASH with Digital Therapeutics Expertise to Combat Clinical Depression Other OTC:EHVVF Read More »